Skip to content

Clinical trials

Completed Phase 2/3 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 2/3 Status: Completed Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20131
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion1
Assistance Publique - Hôpitaux de Paris1
Daniels, Craig E., M.D.1
Royal Brompton & Harefield NHS Foundation Trust1
Tokyo University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis5
Scleroderma, Diffuse3
Scleroderma, Systemic3
Lung Diseases, Interstitial2
Arthritis1
Autoimmune Diseases1
Collagen Diseases1
Connective Tissue Diseases1
Dermatomyositis1
Idiopathic Pulmonary Fibrosis1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.